SCHEMBL4936685

SCHEMBL4936685

CC(=O)Nc1nccc(Oc2ccc(NC(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)cc2)n1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 3/20 0.82
CDK2 P24941 2/20 0.82
CDK1 P06493 1/20 0.82
SRC P12931 7/20 0.71
ABL1 P00519 6/20 0.67
FGFR4 P22455 6/20 0.61
KDR P35968 3/20 0.59
MAP3K7 O43318 2/20 0.59
MAP4K2 Q12851 2/20 0.59
MAPK14 Q16539 2/20 0.59
MAP3K20 Q9NYL2 2/20 0.59
RET P07949 2/20 0.59
FGFR1 P11362 2/20 0.59
HCK P08631 2/20 0.59
STK25 O00506 1/20 0.59
CIT O14578 1/20 0.59
MAP2K7 O14733 1/20 0.59
IKBKB O14920 1/20 0.59
AURKA O14965 1/20 0.59
GAK O14976 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3676641 0.90 CDK2 (1.00) CDK8CDK2CDK1SRCABL1
SCHEMBL29678277 0.90 CDK2 (1.00) CDK8CDK2CDK1SRCABL1
SCHEMBL4929546 0.87 CDK8 (0.71) CDK8CDK2CDK1SRCABL1
SCHEMBL4940425 0.85 CDK8 (0.69) CDK8CDK2CDK1SRCABL1
SCHEMBL22528915 0.85 SRC (0.76) CDK8CDK2CDK1SRCABL1
SCHEMBL4936330 0.84 CDK8 (0.68) CDK8CDK2CDK1SRCABL1
SCHEMBL13991162 0.84 CDK8 (0.68) CDK8CDK2CDK1SRCABL1
SCHEMBL3681671 0.84 CDK2 (0.88) CDK8CDK2CDK1SRCABL1
SCHEMBL29678397 0.84 CDK2 (0.88) CDK8CDK2CDK1SRCABL1
SCHEMBL19911109 0.83 SRC (1.00) CDK8CDK2CDK1SRCABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US claimed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases RET, PRKDC, PRKACA CDK8 170/4885CDK2 83/4885CDK1 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.